Consecutive cases of acute phacomorphic angle closure from December 2009 to December 2010 were recruited from Caritas Medical Center, Hong Kong Special Administrative Region, People’s Republic of China. Patient’s intraocular pressure was lowered initially either by ALPI or systemic acetazolamide. The selection between the two initial treatments was randomized. The randomization was part of a treatment protocol of another study comparing the effects of initial treatments in phacomorphic angle closure. Those receiving ALPI received laser applications 360° to the peripheral iris with power titrated to achieve visualized contractions of the iris. All ALPI was performed by a single surgeon (JL). Those receiving systemic acetazolamide received intravenous acetazolamide 500 mg stat followed by oral acetazolamide 250 mg four times daily and slow-release potassium chloride tablets 600 mg twice daily if there were no systemic contraindications. All patients were put on the following eye drops: Atropine 1 % daily (Alcon Inc., Hünenberg, CH-6331, Switzerland), Pred forte1% four times daily (Allergan Inc., Irvine, CA 92623-9534, USA), and Timolol 0.5 % twice daily (Santen Pharmaceutical Co. Ltd., Osaka, 533-8651, Japan) in the attack eye. Patients with presenting IOP higher than 60 mmHg or IOP higher than 40 mmHg after 2 h of treatment were given 200 ml of 20 % mannitol intravenously over 1 h. Hourly IOP was documented until it was below 25 mmHg.
Cases were included for consenting individuals with a first episode of acute (<14 days) phacomorphic angle closure with an IOP more than 40 mmHg. The diagnosis of phacomorphic angle closure was based on the presence of an intumescent cataract and signs of acute angle closure: conjunctival injection, shallow anterior chamber, corneal edema in the index eye or an open angle in the contralateral eye as determined by gonioscopy [2]. Cases were excluded if IOP lowering treatment was given for this acute episode prior to the study or where ALPI was not possible either due to a severely edematous cornea or uncooperative patient.
All cases received extracapsular cataract extraction (ECCE) and intraocular lens (IOL) insertion under regional anesthesia by one of the three glaucoma surgeons at our center within 3 days of presentation to our clinic. All glaucoma medications were discontinued immediately after the cataract extraction. ECCE was chosen over phacoemulsification due to less endothelial damage from ultrasound energy and phacoemulsification would impose greater surgical risk in the setting of phacomorphic angle closure especially in the presence of any residual corneal edema and zonule loosening [2].
Patients were followed up on day one, 1 week, 1 month, 3 months and as needed postoperatively and IOP was measured by Goldman applanation tonometry in each visit. Best corrected visual acuity (BCVA) was measured by Snellen chart at 1 month postoperatively. The trabecular-iris angle was measured by gonioscopy and ultrasound biomicroscopy (UBM) at 3 months post attack.
Stratus optical coherence tomography (Carl Zeiss Meditec Inc., Dublin, CA, USA) was used for RNFL in micrometers (μm) and vertical cup-disc ratio (VCDR) measurements in both eyes at 3 and 9 months post phacomorphic attack. The pupils were pharmacologically dilated to at least 5 mm prior to OCT and all scans were performed using fast scan mode by a single operator (JL) with 4 years of operating experience. All scans had centered alignment and signal strength of six or more, suboptimal scans were repeated. Multiple scans (two to four per eye) were obtained per secession and the scan with the highest quality (highest signal strength and most centred alignment) was selected.
Visual field was assessed at 9 months post cataract extraction with the Humphrey Field Analyzer (Carl Zeiss Ophthalmic Systems, Inc., Dublin, CA, USA) using Swedish interactive threshold algorithm fast (SITA Fast), 24-2 strategy.
Statistics
Paired Wilcoxon matched pairs (signed rank) test was used to compare the RNFL in the following settings:
-
(1)
Between the eye with phacomorphic angle closure and the contralateral (non-attack) eyes at 3 months.
-
(2)
Between the eye with phacomorphic angle closure at 3 and 9 months.
-
(3)
Between the contralateral eye at 3 and 9 months.
For the above tests, the four quadrants and average thickness were compared independently in a planned comparison basis.
Mann–Whitney U test was used to compare the RNFL and VCDR between eye with phacomorphic angle closure and contralateral eye as well as to compare the pattern standard deviation (PSD) on the VF between the two eyes. Pearson’s correlation was used to determine correlation between RNFL and PSD.
For all statistical calculations p < 0.05 was considered significant and all means were presented as mean ± standard deviation.
The institutional review board of the Hospital Authority of Hong Kong approved this study. The study protocol followed the principles in the Declaration of Helsinki. Informed consent was obtained from all patients prior to all treatments and investigations. The authors declare no proprietary interest or financial sponsorship.